Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

1.

Endothelial cell-specific chemotaxis receptor (ECSCR) enhances vascular endothelial growth factor (VEGF) receptor-2/kinase insert domain receptor (KDR) activation and promotes proteolysis of internalized KDR.

Kilari S, Remadevi I, Zhao B, Pan J, Miao R, Ramchandran R, North PE, You M, Rahimi N, Wilkinson GA.

J Biol Chem. 2013 Apr 12;288(15):10265-74. doi: 10.1074/jbc.M112.413542. Epub 2013 Feb 7.

PMID:
23393131
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Endothelial cell-specific chemotaxis receptor (ecscr) promotes angioblast migration during vasculogenesis and enhances VEGF receptor sensitivity.

Verma A, Bhattacharya R, Remadevi I, Li K, Pramanik K, Samant GV, Horswill M, Chun CZ, Zhao B, Wang E, Miao RQ, Mukhopadhyay D, Ramchandran R, Wilkinson GA.

Blood. 2010 Jun 3;115(22):4614-22. doi: 10.1182/blood-2009-10-248856. Epub 2010 Jan 19.

PMID:
20086248
[PubMed - indexed for MEDLINE]
Free PMC Article
3.
4.

Src kinase becomes preferentially associated with the VEGFR, KDR/Flk-1, following VEGF stimulation of vascular endothelial cells.

Chou MT, Wang J, Fujita DJ.

BMC Biochem. 2002 Dec 31;3:32. Epub 2002 Dec 31.

PMID:
12509223
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Antiangiogenic effect by SU5416 is partly attributable to inhibition of Flt-1 receptor signaling.

Itokawa T, Nokihara H, Nishioka Y, Sone S, Iwamoto Y, Yamada Y, Cherrington J, McMahon G, Shibuya M, Kuwano M, Ono M.

Mol Cancer Ther. 2002 Mar;1(5):295-302.

PMID:
12489845
[PubMed - indexed for MEDLINE]
Free Article
6.
7.

Heterotrimeric G alpha q/G alpha 11 proteins function upstream of vascular endothelial growth factor (VEGF) receptor-2 (KDR) phosphorylation in vascular permeability factor/VEGF signaling.

Zeng H, Zhao D, Yang S, Datta K, Mukhopadhyay D.

J Biol Chem. 2003 Jun 6;278(23):20738-45. Epub 2003 Apr 1.

PMID:
12670961
[PubMed - indexed for MEDLINE]
Free Article
8.

Activation and translocation of PKCdelta is necessary for VEGF-induced ERK activation through KDR in HEK293T cells.

Kuriyama M, Taniguchi T, Shirai Y, Sasaki A, Yoshimura A, Saito N.

Biochem Biophys Res Commun. 2004 Dec 17;325(3):843-51.

PMID:
15541367
[PubMed - indexed for MEDLINE]
9.

Promoter methylation status of VEGF receptor genes: a possible epigenetic biomarker to anticipate the efficacy of intracellular-acting VEGF-targeted drugs in cancer cells.

Kim J, Hwang J, Jeong H, Song HJ, Shin J, Hur G, Park YW, Lee SH, Kim J.

Epigenetics. 2012 Feb;7(2):191-200. doi: 10.4161/epi.7.2.18973.

PMID:
22395469
[PubMed - indexed for MEDLINE]
10.

Pseudolarix acid B inhibits angiogenesis by antagonizing the vascular endothelial growth factor-mediated anti-apoptotic effect.

Tan WF, Zhang XW, Li MH, Yue JM, Chen Y, Lin LP, Ding J.

Eur J Pharmacol. 2004 Sep 24;499(3):219-28.

PMID:
15381043
[PubMed - indexed for MEDLINE]
11.

Both Kdr and Flt1 play a vital role in hypoxia-induced Src-PLD1-PKCĪ³-cPLA(2) activation and retinal neovascularization.

Singh NK, Hansen DE 3rd, Kundumani-Sridharan V, Rao GN.

Blood. 2013 Mar 7;121(10):1911-23. doi: 10.1182/blood-2012-03-419234. Epub 2013 Jan 14.

PMID:
23319572
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor.

Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin CH.

J Biol Chem. 1994 Oct 28;269(43):26988-95.

PMID:
7929439
[PubMed - indexed for MEDLINE]
Free Article
13.

Protein kinase C regulates FLT1 abundance and stimulates its cleavage in vascular endothelial cells with the release of a soluble PlGF/VEGF antagonist.

Raikwar NS, Liu KZ, Thomas CP.

Exp Cell Res. 2013 Oct 15;319(17):2578-87. doi: 10.1016/j.yexcr.2013.07.005. Epub 2013 Jul 30.

PMID:
23911939
[PubMed - indexed for MEDLINE]
14.

The Shc-related adaptor protein, Sck, forms a complex with the vascular-endothelial-growth-factor receptor KDR in transfected cells.

Warner AJ, Lopez-Dee J, Knight EL, Feramisco JR, Prigent SA.

Biochem J. 2000 Apr 15;347(Pt 2):501-9.

PMID:
10749680
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Suppression of experimental choroidal neovascularization utilizing KDR selective receptor tyrosine kinase inhibitor.

Takeda A, Hata Y, Shiose S, Sassa Y, Honda M, Fujisawa K, Sakamoto T, Ishibashi T.

Graefes Arch Clin Exp Ophthalmol. 2003 Sep;241(9):765-72. Epub 2003 Aug 23.

PMID:
12937991
[PubMed - indexed for MEDLINE]
16.

Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation.

Gerber HP, McMurtrey A, Kowalski J, Yan M, Keyt BA, Dixit V, Ferrara N.

J Biol Chem. 1998 Nov 13;273(46):30336-43.

PMID:
9804796
[PubMed - indexed for MEDLINE]
Free Article
17.

Pro-angiogenic activity of astragaloside IV in HUVECs in vitro and zebrafish in vivo.

Zhang Y, Hu G, Li S, Li ZH, Lam CO, Hong SJ, Kwan YW, Chan SW, Leung GP, Lee SM.

Mol Med Rep. 2012 Mar;5(3):805-11. doi: 10.3892/mmr.2011.716. Epub 2011 Dec 15.

PMID:
22179585
[PubMed - indexed for MEDLINE]
18.

Analysis of anti-proliferative and chemosensitizing effects of sunitinib on human esophagogastric cancer cells: Synergistic interaction with vandetanib via inhibition of multi-receptor tyrosine kinase pathways.

Lyros O, Mueller A, Heidel F, Schimanski CC, Gockel I, Galle PR, Lang H, Moehler M.

Int J Cancer. 2010 Sep 1;127(5):1197-208. doi: 10.1002/ijc.25137.

PMID:
20039326
[PubMed - indexed for MEDLINE]
19.
20.

Transactivation of KDR/Flk-1 by the B2 receptor induces tube formation in human coronary endothelial cells.

Miura S, Matsuo Y, Saku K.

Hypertension. 2003 May;41(5):1118-23. Epub 2003 Mar 24.

PMID:
12654712
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk